NORTH ANDOVER, Mass., April 25 /PRNewswire-FirstCall/ -- Andover Medical, Inc. , a single source provider of orthopedic, podiatric and urological durable medical equipment (“DME”) and incontinence treatment solutions, announced today that the Company has retained the services of Boston-based Equity Performance Group (EPG). Equity Performance Group will provide Andover Medical with full-service investor relations and business communications strategies tailored to increase its marketability and exposure in the financial community. An online investor page, featuring a one page Investment Profile, is now available and will be frequently updated to include the latest news, media clips and corporate marketing material of Andover Medical Inc.
The Investment Profile consists of a comprehensive corporate summary of Andover Medical, the Company’s business model, and an industry overview. The report also includes investment catalysts and recent news. The following is an excerpt from the Investment Profile:
“By acquiring and consolidating local DME (Durable Medical Equipment) providers across the country with revenues between 1 and 10 million dollars, Andover will be favorably positioned to leverage its large national presence and client base... Andover is led by a multi-faceted management team with over 30 years of experience in the biotech, pharmaceutical and health care industries.”
To view the complete Investment Profile and for full disclosure terms, please visit: http://www.equityperformancegroup.com/clients_adov.php.
About The Equity Performance Group:
The Equity Performance Group provides publicly traded micro-cap companies with services to enhance their trading performance. The Company’s advisory services and proactive campaigns are custom designed to dramatically improve each client’s exposure by communicating financial catalysts; transition and turnaround strategies; and breaking news to a broad retail and institutional audience within the financial community. Improved trading performance and an expanding shareholder base can facilitate capital raises, secondary offerings, merger and acquisition activity, float diversification, and also can ensure that listing/exchange requirements are continuously met. For more information, including disclaimers, visit http://www.equityperformancegroup.com.
About Andover Medical, Inc.:
Andover Medical, Inc. (AMI) is building a single source provider of orthopedic, podiatric and urological durable medical equipment (“DME”) and incontinence treatment solutions. The Company intends to establish a nationwide subsidiary network and plans to offer practitioners the largest selection of competitively priced brand-name durable medical equipment, and urodynamic diagnostic and treatment products. For more information, please call (978) 557-1001 or visit www.andovermedical.com.
Forward-Looking Statements:
This press release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. All statements other than statements of historical facts included in this press release are forward-looking statements. These forward looking statements include “By [Andover] acquiring and consolidating local DME (Durable Medical Equipment) providers across the country with revenues between 1 and 10 million dollars, Andover will be favorably positioned to leverage its large national presence and client base” and “Andover’s intent to establish a nationwide subsidiary network and plans to offer physicians the largest selection of competitively priced brand-name durable medical equipment, and urodynamic diagnostic and treatment products.” All forward-looking statements speak only as of the date of this press release. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance, achievements or transactions of AMI and its affiliates to be materially different from any future results, performance, achievements or transactions expressed or implied by such forward-looking statements. Such risks, uncertainties and other factors which, could impact the Company and the forward-looking statements contained herein are included in the Company’s filings with the Securities and Exchange Commission. The Company assumes no obligation to update or supplement forward-looking statements that become untrue because of subsequent events.
Andover Medical, Inc.
CONTACT: Edwin Reilly, CEO of Andover Medical, Inc., +1-978-557-1001, ext.11; or investors, Gary Geraci of Equity Performance Group, +1-617-723-2373,gary@equityperfgp.com
